Search Results

I was recently awarded a Marie Sklodowska Curie PostDoc Fellowship in order to investigate and find better

the nerve synapse might impact integrated behavior and what we might learn from these mechanisms to cure After a doctoral training at the Pierre and Marie Curie University in Paris and a short internship at the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles Schwartz in Paris From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc created the INSERM/CNRS laboratory on the "Neurobiology of Psychiatric Disorders", at the University of Paris-Sorbonne

the nerve synapse might impact integrated behavior and what we might learn from these mechanisms to cure After doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles Schwartz in Paris From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc Neurobiology of Psychiatric Disorders," first in Créteil with Marion Leboyer, then at the University of Paris-Sorbonne

Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Maria Waldhoer on the web LinkedIn T witter Pubmed Dr. GPCR About Dr. JoAnn Trejo "Dr. GPCR About Anne Marie Quinn "Anne Marie Quinn has a long and varied work experience in the biocomputing Anne Marie Quinn attended Yale University from 1998 to 2000, where they earned a Master of Public Health Anne Marie Quinn on the web Google Scholar The Org LinkedIn Twitter Dr. GPCR Enjoying the Dr.

Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining

<< Back to podcast list Strategic Partner(s) Chris Langmead Chris Langmead is Professor, Deputy Director the field of psychiatry, where he has led multiple projects into late stage preclinical development, many Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience

Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

Lange and Annie Mary Lyle Chair in Cardiovascular Research, and Professor of Pharmacology, Ophthalmology Her laboratory has been involved in studying G protein coupled signal transduction for many years and

." - Anne Marie Quinn, CEO Montana Molecular !

Kari Johnson About this episode Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

Anne Marie Quinn, CEO Montana Molecular Before working with Yamina, we were generating high-quality data

They’re stalling because of slow decisions, misapplied models, and buried priorities.

Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

Chris Evans at UCLA.

She began her Ph.D. at Imperial College London with Prof Aylin Hanyaloglu, Prof Gary Frost, and Dr.

California at Irvine, studying the regulation of ionotropic glutamate receptors under the direction of Gary

Maria Majellaro—and learn what their new partnership with Dr. curiosity to biotech force. “We started with GPCRs, but now we’re expanding to many new targets. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge at the University of Bari (Italy) in 2018.

Curious about how these advances could impact drug discovery? Curious about how these advances could impact drug discovery?

. << Back to podcast list Strategic Partner(s) From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Ajay Yekkirala shares the pivotal moments that transformed him from a curious PhD student into a GPCR Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. translational innovation Biotech investors and strategic leaders seeking new drug development models Anyone curious His story is one of relentless curiosity, humility in the face of complexity, and an unshakable belief

Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship Ben Clements #GPCRresearch #DrGPCR #GPCRpodcast #OpioidPharmacology #DrugDiscovery Published on May 15 Tune in for a masterclass on translational pharmacology, curiosity-driven science, and meaningful mentorship

It’s not just about learning the techniques; it’s about curiosity! It’s not just about learning the techniques; it’s about curiosity!

Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Broichhagen About the Guests Maria Majellaro, PhD Dr. Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off She earned her PhD in medicinal chemistry from the University of Bari in 2018, including research training Guests on The Web Maria Majellaro LinkedIn ResearchGate Ecosystem Johannes Broichhagen LinkedIn Google

Maria Majellaro Co-Funder and CSO Dr. Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari Maria Majellaro "We always start with the problem, then generate the right compound using our chemistry Maria Majellaro, CSO of Celtarys. “Working with Dr.

pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves pharmacology in discovery strategy 🟢 Black & Leff’s operational model—finally made practical 🟢 Binding curves

ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many 2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr Published on May ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many

GPCR Podcast - The Voice of the Community Whether you’re a scientist, student, or just curious, you’ll

how his experiences at the University of Chicago and the University of Michigan shaped his scientific curiosity

scaffolds like thiazolidines and xanthinediones, Ben is helping define how structurally different PAMs may “It doesn’t matter how many cool, fun tools you have. With clarity, curiosity, and a collaborative spirit, Ben reminds us that impactful science isn’t just

That gap in care sparked a curiosity that became a career. struggling to grip mice in early animal studies to thesis delays during COVID-19, Serafini's journey is marked

Like many, his path to GPCR research wasn’t linear—it evolved through academic exploration and mentorship Advice, Tools, and the Future of GPCR Research Nicoli offered advice to wet-lab scientists curious about